ArticleJournal of medicinal chemistry2024

First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity

Sachin Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.